Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v2-FR
Language French French
Date Updated 2017-09-25 2017-03-13
Drug Identification Number 02244614 02244614
Brand name MITOXANTRONE INJECTION USP MITOXANTRONE INJECTION USP
Common or Proper name MITOXANTRONE MITOXANTRONE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MITOXANTRONE HYDROCHLORIDE MITOXANTRONE HYDROCHLORIDE
Strength(s) 2mg 2mg
Dosage form(s) Solution Solution
Route of administration Intravenous / Intraveineux Intravenous / Intraveineux
Packaging size 20mg/10mL x 1 20mg/10mL x 1
ATC code L01DB L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug. Other (Please describe in comments)
Anticipated start date
Actual start date 2015-08-21 2015-08-21
Estimated end date 2017-09-25 Unknown
Actual end date 2017-09-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Manufacturing Related Issues
Health Canada comments